[良性前列腺增生症]
Sarelis Infante Hernández1, Juan Gómez Rivas2, Jesús Moreno Sierra2
1Servicio de Urología, Hospital Clínico San Carlos, Madrid, España.
概括
良性前列腺增生症 (BPH) 是老年男性常见的疾病,由于前列腺扩大,导致下泌尿道症状. 对BPH的治疗决定是根据生活质量和临床因素的个性化.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 老年病的医生 老年病的医生
背景情况:
- 良性前列腺增生 (BPH) 是前列腺扩大的一个组织病理发现.
- BPH通常会导致下泌尿道症状 (LUTS).
- 随着年龄的增长,LUTS的患病率会增加,影响生活质量.
研究的目的:
- 审查BPH的诊断和治疗.
- 强调个性化,基于风险的BPH管理方法.
主要方法:
- 对临床参数和患者生活质量的审查.
- 评估保守,药物和手术治疗选择.
主要成果:
- 在BPH中前列腺扩大阻塞了下部泌尿道.
- 患者的咨询是由典型的临床症状驱动的.
- 客观的临床参数和生活质量是治疗决策的关键.
结论:
- 个性化,基于风险的方法对于管理BPH至关重要.
- 对BPH的治疗策略应根据患者的具体需求量身定制.
- 保守性,药物或手术干预是以全面评估为指导的.
相关概念视频
Disorders of the Male Reproductive System
380
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
380
Accessory Glands of the Male Reproductive System
1.5K
The accessory ducts involved in sperm maturation and transportation include the epididymides, vasa deferentia, ejaculatory ducts, and urethra. These ducts play a critical role in the maturation, storage, and transportation of sperm from the testes to the urethra, where it is then released during ejaculation.
The epididymis is a small, comma-shaped organ located at the back of each testicle. The epididymis can be divided into three main parts: the head, body, and tail. The head of the epididymis...
The epididymis is a small, comma-shaped organ located at the back of each testicle. The epididymis can be divided into three main parts: the head, body, and tail. The head of the epididymis...
1.5K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
165
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
165
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
143
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
143
Pulmonary Hypertension: Classification and Pathogenesis
164
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
164
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
664
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
664


